Revelation Biosciences Inc.
13F holders, Q1 2026 (March 31)1holders −6
1new positions
0sold out
$1.20avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Revelation Biosciences Inc. in their 13F filings, down 6 from Q2 2025. 1 opened new positions and 0 sold out. The largest holder was Harbour Investments, Inc. ($49).
- Company
- Revelation Biosciences Inc.
- CUSIP
- 76135L606
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $49 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q1 2026: 41 shares bought, net +41 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Harbour Investments, Inc. | 0.00% | New | 41 | $49 |
"% of holder's portfolio" is REVELATION BIOSCIENCES INC's weight in each manager's 13F, not the share of Revelation Biosciences Inc. the manager owns.